Abvc Biopharma (ABVC) Interest Paid (2012 - 2026)
Abvc Biopharma (ABVC) recorded Interest Paid of $9.00 in Q3 2026, down 99.8% from $4,736 a year earlier and down 97.6% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Interest Paid (2012 - 2026) Analysis & Trends
On a TTM basis, Abvc Biopharma's Interest Paid came in at $14,019 as of Sep 30, 2026; for FY2025, it came in at $31,518, up 39.8% from FY2024.
- Annual Interest Paid has a five-year compound annual growth rate of -31.5% (FY2020 to FY2025).
- Across earlier years, Interest Paid came in at $22,539 in FY2024 (-32.1%), $33,180 in FY2023 (-88.4%), $285,465 in FY2022 (-14.5%) and $333,873 in FY2021 (+60.1%).
- The Q3 2026 figure is the lowest quarterly Interest Paid since Q4 2024.
- On a year-over-year basis, Interest Paid has declined for three consecutive quarters, with an average decline of 60.1% over the last six quarters.
- Peak year-over-year performance for Interest Paid in the last five years was growth of 618.1% in Q3 2024, against a decline of 99.8% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $380.00 (Q2 2026), $4,190 (Q1 2026) and $9,440 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Paid (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -1.78 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 283.00 Mn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 9.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.00 |
| Jun 30, 2026 | 380.00 |
| Mar 31, 2026 | 4,190.00 |
| Dec 31, 2025 | 9,440.00 |
| Sep 30, 2025 | 4,736.00 |
| Jun 30, 2025 | 5,274.00 |
| Mar 31, 2025 | 5,231.00 |
| Dec 31, 2024 | -36,980.00 |
| Sep 30, 2024 | 43,034.00 |
| Jun 30, 2024 | 10,784.00 |
| Mar 31, 2024 | 5,701.00 |
| Dec 31, 2023 | 5,655.00 |
| Sep 30, 2023 | 5,993.00 |
| Jun 30, 2023 | -35,131.00 |
| Mar 31, 2023 | 56,663.00 |
| Dec 31, 2022 | 123,724.00 |
| Sep 30, 2022 | 137,393.00 |
| Jun 30, 2022 | -19,494.00 |
| Mar 31, 2022 | 43,842.00 |
| Dec 31, 2021 | 6,231.00 |
API Access
Abvc Biopharma Interest Paid API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-paid&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-paid", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-paid&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();